SCHEMBL1675368

SCHEMBL1675368

c1csc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 19/20 1.00
CLK1 P49759 14/20 1.00
DYRK1A Q13627 13/20 1.00
CLK2 P49760 11/20 1.00
DYRK1B Q9Y463 11/20 1.00
CLK3 P49761 9/20 1.00
CYP2D6 P10635 4/20 0.73
TSHR P16473 4/20 0.73
MAPK1 P28482 4/20 0.73
CYP2C19 P33261 4/20 0.73
ALDH1A1 P00352 3/20 0.73
LMNA P02545 3/20 0.73
CYP2C9 P11712 3/20 0.73
HSD17B10 Q99714 3/20 0.73
RECQL P46063 2/20 0.73
KDM4E B2RXH2 2/20 0.73
MAPT P10636 2/20 0.73
HPGD P15428 2/20 0.73
EGFR P00533 1/20 0.73
ALOX15 P16050 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675458 0.86 CLK4 (0.75) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL29594697 0.84 CLK4 (1.00) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675086 0.84 CLK4 (1.00) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675308 0.84 CLK4 (1.00) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675082 0.81 CLK4 (1.00) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675362 0.80 CLK1 (0.82) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675335 0.79 CLK4 (1.00) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675106 0.79 CLK4 (1.00) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675159 0.79 CLK4 (1.00) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675261 0.78 CLK4 (0.81) CLK4CLK1DYRK1ACLK2DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed